624 related articles for article (PubMed ID: 25911676)
21. Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.
Murray LM; Beauvais A; Gibeault S; Courtney NL; Kothary R
Acta Neuropathol Commun; 2015 Sep; 3():55. PubMed ID: 26374403
[TBL] [Abstract][Full Text] [Related]
22. A Perturbed MicroRNA Expression Pattern Characterizes Embryonic Neural Stem Cells Derived from a Severe Mouse Model of Spinal Muscular Atrophy (SMA).
Luchetti A; Ciafrè SA; Murdocca M; Malgieri A; Masotti A; Sanchez M; Farace MG; Novelli G; Sangiuolo F
Int J Mol Sci; 2015 Aug; 16(8):18312-27. PubMed ID: 26258776
[TBL] [Abstract][Full Text] [Related]
23. Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models.
de la Fuente S; Sansa A; Hidalgo I; Vivancos N; Romero-Guevara R; Garcera A; Soler RM
Cell Death Dis; 2020 Jun; 11(6):487. PubMed ID: 32587237
[TBL] [Abstract][Full Text] [Related]
24. Defects in Motoneuron-Astrocyte Interactions in Spinal Muscular Atrophy.
Zhou C; Feng Z; Ko CP
J Neurosci; 2016 Feb; 36(8):2543-53. PubMed ID: 26911699
[TBL] [Abstract][Full Text] [Related]
25. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
[TBL] [Abstract][Full Text] [Related]
26. Interaction between alpha-COP and SMN ameliorates disease phenotype in a mouse model of spinal muscular atrophy.
Custer SK; Astroski JW; Li HX; Androphy EJ
Biochem Biophys Res Commun; 2019 Jun; 514(2):530-537. PubMed ID: 31060774
[TBL] [Abstract][Full Text] [Related]
27. Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy.
Taylor AS; Glascock JJ; Rose FF; Lutz C; Lorson CL
Transgenic Res; 2013 Oct; 22(5):1029-36. PubMed ID: 23512182
[TBL] [Abstract][Full Text] [Related]
28. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
[TBL] [Abstract][Full Text] [Related]
29. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C
Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366
[TBL] [Abstract][Full Text] [Related]
30. Spinal muscular atrophy patient-derived motor neurons exhibit hyperexcitability.
Liu H; Lu J; Chen H; Du Z; Li XJ; Zhang SC
Sci Rep; 2015 Jul; 5():12189. PubMed ID: 26190808
[TBL] [Abstract][Full Text] [Related]
31. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice.
de la Fuente S; Sansa A; Periyakaruppiah A; Garcera A; Soler RM
Mol Neurobiol; 2019 Jun; 56(6):4414-4427. PubMed ID: 30327977
[TBL] [Abstract][Full Text] [Related]
32. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.
Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L
Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766
[TBL] [Abstract][Full Text] [Related]
33. Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production.
McGivern JV; Patitucci TN; Nord JA; Barabas MA; Stucky CL; Ebert AD
Glia; 2013 Sep; 61(9):1418-1428. PubMed ID: 23839956
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset.
Feng Z; Ling KK; Zhao X; Zhou C; Karp G; Welch EM; Naryshkin N; Ratni H; Chen KS; Metzger F; Paushkin S; Weetall M; Ko CP
Hum Mol Genet; 2016 Mar; 25(5):964-75. PubMed ID: 26758873
[TBL] [Abstract][Full Text] [Related]
35. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn
Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ
Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987
[TBL] [Abstract][Full Text] [Related]
36. Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.
Murray LM; Beauvais A; Bhanot K; Kothary R
Neurobiol Dis; 2013 Jan; 49():57-67. PubMed ID: 22960106
[TBL] [Abstract][Full Text] [Related]
37. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
Liu H; Shafey D; Moores JN; Kothary R
J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
[TBL] [Abstract][Full Text] [Related]
38. Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.
Rindt H; Buckley DM; Vale SM; Krogman M; Rose FF; Garcia ML; Lorson CL
Neuromuscul Disord; 2012 Mar; 22(3):277-85. PubMed ID: 22079083
[TBL] [Abstract][Full Text] [Related]
39. Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse.
McGovern VL; Massoni-Laporte A; Wang X; Le TT; Le HT; Beattie CE; Rich MM; Burghes AH
PLoS One; 2015; 10(7):e0132364. PubMed ID: 26134627
[TBL] [Abstract][Full Text] [Related]
40. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy.
Wen HL; Ting CH; Liu HC; Li H; Lin-Chao S
Neurobiol Dis; 2013 Apr; 52():94-103. PubMed ID: 23268200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
